Banner S E, Carter M, Sanger G J
SmithKline Beecham Pharmaceuticals, Harlow, Essex, U.K.
Neuropharmacology. 1995 Mar;34(3):263-7. doi: 10.1016/0028-3908(94)00159-p.
5-Hydroxytryptamine (5-HT) receptor agonists and antagonists were dosed intravenously (i.v.) and studied for their effects on the depressor cardiovascular pseudoaffective reflex evoked by acute noxious colo-rectal distension in the anaesthetized rat. Methiothepin (100 micrograms kg-1) caused an initial, unsustained blockade of evoked depressor responses whilst ketanserin (100 micrograms kg-1) was without effect. By comparison, ondansetron dose dependently inhibited evoked depressor responses and was maximally active at 100 micrograms kg-1, causing a 57.5 +/- 0.9% reduction. An ID50 value of 36.7 micrograms kg-1 was estimated by regression analysis. In contrast, granisetron caused complete blockade of the depressor response with an ID50 of 0.4 microgram kg-1. Bell-shaped dose-effect curves were demonstrated for both granisetron and ondansetron. Intrathecal dosing with granisetron (100 ng) into the thoracolumbar region of the spinal cord prevented the depressor response to colo-rectal distension, suggesting a spinal site of action. The pseudoaffective depressor responses were not facilitated by pre-dosing with the 5-HT receptor agonists, 8-OH DPAT, alpha-methyltryptamine or 1-phenyl-biguanide. However, 8-OH DPAT (100 micrograms kg-1) facilitated pressor responses. It is suggested that 5-HT3-like receptors may have a role in modulating depressor responses to visceral pain and that in this action different 5-HT3 receptor antagonists are not necessarily equi-effective.
对5-羟色胺(5-HT)受体激动剂和拮抗剂进行静脉给药,并研究其对麻醉大鼠急性有害性结直肠扩张诱发的降压性心血管假情感反射的影响。甲硫哒嗪(100微克/千克)引起诱发的降压反应的初始、非持续性阻断,而酮色林(100微克/千克)则无作用。相比之下,昂丹司琼剂量依赖性地抑制诱发的降压反应,在100微克/千克时活性最大,导致降压反应降低57.5±0.9%。通过回归分析估计ID50值为36.7微克/千克。相反,格拉司琼以0.4微克/千克的ID50完全阻断了降压反应。格拉司琼和昂丹司琼均呈现钟形剂量-效应曲线。向脊髓胸腰段鞘内注射格拉司琼(100纳克)可阻止对结直肠扩张的降压反应,提示其作用部位在脊髓。预先给予5-HT受体激动剂8-OH DPAT、α-甲基色胺或1-苯基双胍并不会促进假情感降压反应。然而,8-OH DPAT(100微克/千克)促进升压反应。提示5-HT3样受体可能在调节对内脏疼痛的降压反应中起作用,并且在这一作用中不同的5-HT3受体拮抗剂不一定等效。